Best Medical Oncologists for Targeted Therapy in Chennai, India

This page lists 3 targeted therapy doctors in Chennai, India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.

Quick answer

This page lists 3 targeted therapy doctors in Chennai, India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.

About Targeted Therapy doctors in Chennai, India

This directory is based on doctors currently listed in GAF Healthcare's registry. Clinical suitability varies by patient; a doctor should review your history and investigations before any treatment decision.

Targeted Therapy doctors

Image not available Featured

Dr. Arun Ramanan V

MBBS, MD (Radiotherapy), DM (Medical Oncology), FIPM, Certificate in Palliative Care
Clinical Lead and Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Gleneagles HealthCity Chennai Chennai, India16+ Years experience
Why consider this doctor?
  • 16+ years of experience in Medical Oncologist
  • Clinical Lead and Senior Consultant, Medical Oncology — Gleneagles HealthCity Chennai, Perumbakkam, Present
  • Medical Oncology Specialist — Gleneagles HealthCity Chennai, Previous tenure with clinical trial and tumour board leadership roles
Expertise & Procedures
  • Chemotherapy administration and management
  • Cancer immunotherapy and checkpoint inhibitor therapy
  • Targeted therapy and molecular cancer treatment
  • Hormone therapy for breast cancer
  • Bone marrow transplantation and stem cell support
View all procedures →
Medical Oncologist Experience: 16+ YearsHospital Affiliation: Gleneagles HealthCity ChennaiHospital accreditation: NABH, JCI
Image not available

Dr. K. R. Gopi

MD, MRCP, Medical Oncology Certification, European Board Certification, DNB
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Dr. Rela Institute and Medical Centre Chennai, India30+ Years experience
Why consider this doctor?
  • 30+ years of experience in Medical Oncologist
  • Senior Consultant — Medical Oncology, Dr. Rela Institute and Medical Centre, Chennai, Present
  • Consultant — Medical Oncology, Apollo Speciality Hospital, Chennai
Expertise & Procedures
  • Chemotherapy Administration and Management
  • Cancer Immunotherapy (checkpoint inhibitors)
  • Targeted Therapy for Solid Tumours
  • Hormone Therapy for Breast Cancer
  • Hormone Therapy for Prostate Cancer
View all procedures →
Medical Oncologist Experience: 30+ YearsHospital Affiliation: Dr. Rela Institute and Medical CentreHospital accreditation: NABH, NABL
Image not available

Dr. Ponni Sivaprakasam

MBBS, MRCPCH, Fellowship Clinical, Fellow, BMT & Co-ordination
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Gleneagles Global Health City Chennai, India17+ Years experience
Why consider this doctor?
  • 17+ years of experience in Medical Oncologist
  • Senior Consultant, Medical Oncology — Gleneagles Global Health City, Chennai, Present
  • Consultant Paediatric Haemato-Oncology — Mazumdar Shaw Cancer Centre, Bangalore
Expertise & Procedures
  • Bone marrow transplantation (autologous and allogeneic)
  • Stem cell mobilization and apheresis
  • Chemotherapy administration and management
  • CAR-T cell therapy infusion and monitoring
  • Cancer immunotherapy and targeted therapy protocols
View all procedures →
Medical Oncologist Experience: 17+ YearsHospital Affiliation: Gleneagles Global Health CityHospital accreditation: NABH, JCI

Hospitals where these doctors practise

Gleneagles Global Hospital🇮🇳 Chennai, India
Starting from$300

Gleneagles Global Hospital

Est. 1999
NABHNational Accreditation Board for Hospitals & Healthcare Providers accreditationJCIJoint Commission International accreditation
Targeted TherapyMedical OncologyCardiac SurgeryCardiology
2+
Doctors for Targeted Therapy
4.7
112 reviews
1000+
Beds
27+
Years Since Founded
Dr. Arun Ramanan VDr. Ponni Sivaprakasam
Dr. Rela Institute and Medical Centre🇮🇳 Chennai, India
Starting from$300

Dr. Rela Institute and Medical Centre

Est. 2018
NABHNational Accreditation Board for Hospitals & Healthcare Providers accreditationNABLNational Accreditation Board for Testing and Calibration Laboratories accreditation
Targeted TherapyMedical OncologyCardiac SurgeryCardiology
1+
Doctors for Targeted Therapy
4.7
108 reviews
450+
Beds
8+
Years Since Founded
Dr. K. R. Gopi

Why consider treatment in India?

Many international patients consider India for leukemia treatment for several reasons, including:

More affordable estimates

Competitive indicative costs compared with many other countries, for similar clinical standards.

Internationally accredited hospitals

Hospitals experienced in treating international patients.

Experienced specialists

Doctors who regularly manage similar cases.

Care coordination support

A team to help with planning, medical translation and follow-up.

About the Procedure

What is Targeted Therapy?

Targeted therapy uses drugs designed to specifically identify and attack cancer cells based on genetic mutations, proteins, or receptors, while sparing normal healthy cells. It is used across breast, lung, colorectal, gastric, liver, pancreatic, prostate, ovarian, head & neck cancers, leukemia, lymphoma, and multiple myeloma, often guided by biomarker or genomic testing. India offers internationally accredited cancer centres with access to the latest targeted agents at a fraction of Western costs.

Who may be considered?

Targeted Therapy may be considered after a qualified specialist reviews your reports and medical history. Suitability varies from person to person and must be assessed by your treating doctor.

How does it work?

Tumor tissue or blood samples are analyzed for specific mutations (e.g., HER2, EGFR, ALK, KRAS, BRCA) to determine eligibility for a matched targeted drug.

3 approaches available for this procedure:

Biomarker/Genomic Testing & Drug Selection

Essential First Step

Tumor tissue or blood samples are analyzed for specific mutations (e.g., HER2, EGFR, ALK, KRAS, BRCA) to determine eligibility for a matched targeted drug.

Comprehensive Investigations

Estimated cost: $300 - $1,500

Tumor biopsy, IHC/FISH testing, next-generation sequencing (NGS) panel, liquid biopsy, complete blood count (CBC), liver and kidney function tests

Treatment / Procedure Estimate

Estimated cost in India: $300 - $2,000

Stay in India

Pre-procedure stay (outside hospital): ~2 days
Hospitalisation: 0 days (outpatient)
Recovery period (outside hospital): ~1 day
Total stay: approx 3 days

Usually Included in Hospital Package

  • Oncologist consultation
  • Tissue/blood sample processing
  • Genomic report interpretation
  • Tumor board review

Usually Not Included

  • International shipping of external samples
  • Repeat biopsy if sample inadequate
  • Second confirmatory pathology opinion

Recovery and follow-up

Most patients tolerate targeted therapy on an outpatient or short-stay basis, with periodic monitoring for side effects such as fatigue, skin reactions, or organ toxicity; response is typically reassessed via imaging every 2-3 treatment cycles.

Risks

Potential risks include infusion reactions, cardiotoxicity, skin and gastrointestinal side effects, elevated liver enzymes, and, less commonly, resistance development requiring drug switch.

Alternatives

Depending on cancer type and stage, alternatives may include conventional chemotherapy, immunotherapy, hormonal therapy, radiation, or surgical resection, often used in combination with or instead of targeted therapy.

What we need to prepare a formal estimate

Share whatever you have — the care team will confirm the final checklist after reviewing your case.

Reports required

  • Histopathology and biopsy report
  • IHC/FISH biomarker results (HER2, ER/PR, etc.)
  • Next-generation sequencing (NGS) or mutation panel report
  • Recent CT/PET-CT/MRI imaging
  • Complete blood count and organ function tests
  • Prior treatment and chemotherapy history
  • Discharge summaries from previous hospitalizations
  • Current medication list

Patient information needed

  • Cancer type, stage, and site of primary tumor
  • Prior treatments including surgery, chemotherapy, radiation
  • Known genetic mutations or biomarker status if tested
  • Current performance status and comorbidities
  • Allergy history, especially to biologic drugs
  • Cardiac history if cardiotoxic drugs are anticipated
  • Insurance or budget considerations
  • Availability of a caregiver/companion during treatment

Costs shown are indicative planning estimates based on typical pricing across leading Indian hospitals. They are not a quote — actual pricing depends on your case complexity, hospital choice, and length of stay. Share your reports for a personalized estimate.

Want a formal estimate?

Share your reports and patient information so our care coordination team can review your case.

How this directory is built

Doctors are matched using the specialty, location, condition (Targeted Therapy) and procedure (Targeted Therapy) recorded in their profiles. Inclusion is not an endorsement and does not guarantee a treatment outcome.

Need help with the next step?

Share your needs with our care coordination team for information about doctors and hospitals.

Common questions

FAQs about Targeted Therapy in Chennai, India

What is Leukemia?
Leukemia is a group of blood cancers originating in the bone marrow, where abnormal white blood cells multiply uncontrollably and interfere with the production of normal blood cells. The main types include acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), and chronic myeloid leukemia (CML), each requiring a distinct clinical approach.
What are the symptoms and health risks of Leukemia?
Common symptoms include persistent fatigue, unexplained weight loss, recurrent infections, easy bruising or bleeding, swollen lymph nodes, night sweats, bone or joint pain, and an enlarged spleen or liver. Acute leukemias tend to present with symptoms that develop over days to weeks, while chronic forms may cause few or no symptoms early on and are sometimes detected incidentally on routine blood tests. It is important to note that these symptoms overlap with many other conditions, and experiencing them does not establish a leukemia diagnosis—only appropriate medical investigation can do that.
How is Leukemia diagnosed?
Diagnosis typically begins with a complete blood count (CBC) showing abnormal white cell levels, followed by a peripheral blood smear to examine cell appearance. A bone marrow biopsy and aspiration are usually required to confirm the diagnosis, determine the specific leukemia subtype, and assess the proportion of blast cells present. Further investigations—including cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, and molecular testing for mutations such as BCR-ABL, FLT3, or NPM1—are used to classify the disease precisely and guide risk stratification, which directly influences treatment planning.
How is Leukemia treated?
Treatment strategy depends on the leukemia type, subtype, risk classification, a patient's age, overall health, and response to initial therapy. Acute leukemias generally require prompt intervention—commonly chemotherapy delivered in structured induction and consolidation phases—while some chronic leukemias may be managed initially with targeted oral therapies or careful monitoring without immediate systemic treatment. For eligible patients, particularly those with high-risk or relapsed disease, a stem cell transplant may be recommended to achieve longer-term disease control; immunotherapy approaches such as CAR-T cell therapy are also available for select cases. All treatment decisions should be individualized through discussion with a qualified oncology team.
Can Leukemia be treated without a procedure?
The majority of leukemia treatment is non-surgical by nature. Chemotherapy, targeted therapy (such as tyrosine kinase inhibitors for CML or APL differentiation therapy), and immunotherapy are the primary systemic treatments. For certain chronic leukemias with a low disease burden and no symptoms—particularly CLL in early stages—an approach of active surveillance, sometimes called 'watch and wait,' may be appropriate under close specialist monitoring before initiating drug therapy.
When is Targeted Therapy considered for Leukemia?
Targeted Therapy may be considered only when it is appropriate for the confirmed diagnosis and the expected benefit outweighs the individual risks. The decision may depend on symptom severity, investigation results, previous treatment, overall health and the patient's goals. A specialist should discuss alternatives and recovery before any procedure is planned.
Which doctor treats Leukemia?
Leukemia is primarily evaluated and managed by a medical oncologist specializing in hematologic malignancies, often referred to as a hematologist-oncologist or clinical hematologist. Complex cases, particularly those involving stem cell transplantation, are co-managed by a transplant hematologist and a multidisciplinary team that may include infectious disease specialists, transfusion medicine physicians, and specialist nurses.
How do I choose a doctor for Leukemia?
When comparing providers for leukemia care, look for a medical oncologist or hematologist-oncologist with documented experience in your specific leukemia type, access to advanced molecular diagnostics and a full range of treatment options including targeted therapy and stem cell transplant capability, and a center that offers structured multidisciplinary tumor board review and long-term follow-up protocols.
What documents do international patients need to share for a medical evaluation?
Share a concise medical summary, symptom timeline, previous diagnoses, investigation and imaging reports, procedure or biopsy reports where relevant, current medicines, allergies and related treatment records. Provide clear copies with translations when needed. The reviewing doctor may request additional information before giving an opinion.
How does GAF Healthcare help international patients plan treatment in India?
Our care coordination team can review the initial information, help identify suitable doctors and hospitals, request a medical opinion where available, explain next steps and indicative cost information, and support practical planning before travel. A remote opinion does not replace an in-person examination or emergency care.